Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?

Ian Glaspole (Footscray, Australia), Ian Glaspole, Nicole Goh, Peter Hopkins, Yuben Moodley, P.N. Reynolds, E.H Walters, Christopher Zappala, Heather Allan, Sally Chapman, Wendy Cooper, Samantha Ellis, Annabelle Mahar, Heather Chaplin, Robert Henson, Sacha Macansh, Sarah Richards, Susan E. Smith, Karen Symons, Eldho Paul, Tamera Corte

Source: International Congress 2015 – IPF: clinical aspects II
Session: IPF: clinical aspects II
Session type: Oral Presentation
Number: 4964
Disease area: Interstitial lung diseases

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ian Glaspole (Footscray, Australia), Ian Glaspole, Nicole Goh, Peter Hopkins, Yuben Moodley, P.N. Reynolds, E.H Walters, Christopher Zappala, Heather Allan, Sally Chapman, Wendy Cooper, Samantha Ellis, Annabelle Mahar, Heather Chaplin, Robert Henson, Sacha Macansh, Sarah Richards, Susan E. Smith, Karen Symons, Eldho Paul, Tamera Corte. Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?. Eur Respir J 2015; 46: Suppl. 59, 4964

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


The lived experience of idiopatic pulmonary fibrosis: A qualitative study
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016


The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

A longitudinal study of anxiety and depression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013


Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey
Source: International Congress 2016 – IPF clinical
Year: 2016



Quality of life of idiopathic pulmonary fibrosis patients
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Quality of life in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005

Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment II
Year: 2016

Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry
Source: International Congress 2014 – ILDs 1
Year: 2014

Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016

Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Sleep quality among patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013

Assessment of nutritional status in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016